Lithium recovery is imperative to accommodate the increase in lithium demand. Salt lake brine contains a large amount of lithium and is one of the most important sources of lithium metal. In this study, LiCO, MnO, and TiO particles were mixed, and the precursor of a manganese-titanium mixed ion sieve (M-T-LIS) was prepared by a high-temperature solid-phase method. M-T-LISs were obtained by DL-malic acid pickling. The adsorption experiment results noted single-layer chemical adsorption and maximum lithium adsorption of 32.32 mg/g. From the Brunauer-Emmett-Teller and scanning electron microscopy results, the M-T-LIS provided adsorption sites after DL-malic acid pickling. In addition, X-ray photoelectron spectroscopy and Fourier transform infrared results showed the ion exchange mechanism of the M-T-LIS adsorption. From the results of the Li desorption experiment and recoverability experiment, DL-malic acid was used to desorb Li from the M-T-LIS with a desorption rate of more than 90%. During the fifth cycle, the Li adsorption capacity of the M-T-LIS was more than 20 mg/g (25.90 mg/g), and the recovery efficiency was higher than 80% (81.42%). According to the selectivity experiment, the M-T-LIS had good selectivity for Li (adsorption capacity of 25.85 mg/g in the artificial salt lake brine), which indicates its good application potential.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254388PMC
http://dx.doi.org/10.3390/ma16114190DOI Listing

Publication Analysis

Top Keywords

salt lake
12
lake brine
12
dl-malic acid
12
manganese-titanium mixed
8
mixed ion
8
adsorption
8
artificial salt
8
acid pickling
8
adsorption capacity
8
lithium
6

Similar Publications

Purpose: To evaluate efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with moderately severe to very severe nonproliferative diabetic retinopathy from the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2 ruboxistaurin (RBX) protein kinase C β inhibitor trials.

Methods: Patients in these 3-year, randomized, placebo-controlled, double-masked, Phase 3 trials had best-corrected Early Treatment Diabetic Retinopathy Study visual acuity ≥45 letters (∼20/125 Snellen), Early Treatment Diabetic Retinopathy Study retinopathy level 47A/B-53E, and no previous panretinal photocoagulation in ≥1 eye. Patients received placebo (N = 401) or RBX 32 mg/day (N = 412).

View Article and Find Full Text PDF

Rationale: Lower respiratory tract infection with Pseudomonas aeruginosa (PA) is associated with increased morbidity in patients with cystic fibrosis (CF). Current treatment guidelines for inhaled antibiotics are not universally followed due to the perception of decreased efficacy, increasing resistance, drug intolerance, and high treatment burden with current aerosol antibiotics. New treatment options for CF pulmonary infections are needed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!